4DMedical signs deal to acquire Imbio for an initial $25 million
MELBOURNE, AUSTRALIA: Respiratory imaging technology company 4DMedical Limited has signed a binding agreement for the acquisition of Imbio, a U.S.-based medical technology company that uses artificial intelligence (AI) to turn standard-of-care CT scans into personalised medicine for transforming the way patients are diagnosed, treated, and managed. Imbio will be acquired for an upfront purchase price…